Clinical Trial Update: Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating metabolic, endocrine, and reproductive effects of drospirenone/ethinyl estradiol alone or with myo-inositol in young women wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Polycystic Ovary Syndrome

Drugs mentioned

• Drospirenone-Ethinyl Estradiol (Drospirenone and Ethinyl Estradiol)
• Myo-inositol (myo-inositol)

Snippet

Sponsor: AGUNCO Obstetrics and Gynecology Centre | Conditions: PCOS, Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED